Effectiveness and Tolerability of Febuxostat vs Allopurinol in patients with Chronic Kidney Disease (CKD) on Conservative Therapy
Journal: Archives of Renal Diseases and Management (Vol.3, No. 1)Publication Date: 2017-06-19
Authors : Filomena Panza Chiara Ralli; Ennio Duranti;
Page : 030-033
Keywords : ;
Abstract
Uric Acid appears to be one of the most important prognostic markers and one of the principal risk factors for cardiovascular diseases. The aim of our study was to assess three groups of patients: a first group treated with Allopurinol (AL), a second group not adequately controlled by treatment with AL or allergic to AL switched to treatment with Febuxostat (AL/FB) and a third group of naive patients immediately treated with Febuxostat (FB). The effectiveness and tolerability of both drugs were therefore assessed over time.
Other Latest Articles
- Factor causing late referral of CKD patients to Nephrology care
- Use of Interpreters for non-native English speaking Kidney Allograft Recipients and outcomes after Kidney Transplantation
- Quality of Life in Patients with Chronic Renal Failure and Some Affecting Factors
- Encapsulating Peritoneal Sclerosis: Different clinical presentations and their management
- Nephrolithiasis in hypercalcemic and normocalcemic primary Hyperparathyroidism
Last modified: 2018-09-17 18:39:20